Top three worldwide capacity in sterile fill-finish manufacturing
Supporting end-to-end late-phase and commercial manufacturing for complex injectable drug products across prefilled syringes, cartridges and vials, with specialized expertise in biologics, segregated cytotoxic lyophilization and ADC fill-finish, plus downstream services including packaging, device assembly and quality release.
End-to-end sterile fill-finish capabilities
ROIS supports late-phase and commercial injectable manufacturing with integrated capabilities spanning prefilled syringes, cartridges and vials, sterile manufacturing technologies from RABS to Isolator processing, and downstream packaging and device assembly.
A dedicated US-based facility adds specialized expertise in OEB5 cytotoxic manufacturing, complementing an Annex 1-compliant network that has hosted inspections from FDA, EMA and other leading global regulatory authorities.
Program support at every stage
Multiple formats
Flexible capacity
Quality-led manufacturing
Complex drug products, manufactured at scale.
Formats
Modalities
Manufacturing technologies
Packaging and integrated services
News and resources
Personalized partnerships. Global reach.
Connect with the ROIS team to explore what true manufacturing partnership looks like, with a shared stake in every program's success, at any scale.